166.5EGP
- Active ingredient
- linagliptin+metformin
- Strength
- 2.5/1000 mg
- Form
- tablet
- Manufacturer
- atco pharma
- Route
- oral.solid
Uses
Used with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Do not use if
Contraindicated in severe renal impairment, metabolic acidosis, and hypersensitivity to either component.
Side effects
Diarrhea, nausea, abdominal discomfort, headache, and nasopharyngitis may occur.
Warnings
Monitor for lactic acidosis, pancreatitis, and declining renal function.
How it works
Combines metformin, which reduces hepatic glucose production, with a DPP-4 inhibitor that enhances incretin activity.
Storage
Store at 20–25°C and protect from humidity.